期刊
EXPERT SYSTEMS WITH APPLICATIONS
卷 208, 期 -, 页码 -出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.eswa.2022.118199
关键词
Cell signaling network; Metaheuristics; Ant colony optimization; High performance computing; MPI; OpenMP
类别
资金
- Ministry of Science and Innovation of Spain [PID2019-104184RB-I00/AEI]
- Xunta de Galicia, Spain
- FEDER funds of the EU (Centro de Investigacion de Galicia accreditation) [ED431C 2021/30]
- Ministry of Science and Innovation of Spain MCIN/AEI [PID2020-117271RB-C22]
- European Union [116030]
- Universidade da Coruna/CISUG
Understanding the deregulation of cell signaling networks is crucial for studying diseases. Computational models, such as CellNOpt, provide a systematic tool to analyze these complex biochemical networks. In this paper, the use of ant colony optimization is proposed as a novel method to improve the limitations of the existing genetic algorithm in CellNOpt, and its performance is demonstrated in liver cancer therapy research.
Acquiring a functional comprehension of the deregulation of cell signaling networks in disease allows progress in the development of new therapies and drugs. Computational models are becoming increasingly popular as a systematic tool to analyze the functioning of complex biochemical networks, such as those involved in cell signaling. CellNOpt is a framework to build predictive logic-based models of signaling pathways by training a prior knowledge network to biochemical data obtained from perturbation experiments. This training can be formulated as an optimization problem that can be solved using metaheuristics. However, the genetic algorithm used so far in CellNOpt presents limitations in terms of execution time and quality of solutions when applied to large instances. Thus, in order to overcome those issues, in this paper we propose the use of a method based on ant colony optimization, adapted to the problem at hand and parallelized using a hybrid approach. The performance of this novel method is illustrated with several challenging benchmark problems in the study of new therapies for liver cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据